Cargando…

Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory

Recently, the incidence of diseases caused by nontuberculous mycobacteria (NTM) has been increasing worldwide, especially in immunocompromised patients and those with potential chronic lung disease. Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, LiuLin, Liang, Li, Zhang, RanRan, Chen, WeiWei, Yu, FangYou, Zhao, Yanlin, Yue, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769768/
https://www.ncbi.nlm.nih.gov/pubmed/36287015
http://dx.doi.org/10.1128/spectrum.02018-22
_version_ 1784854444272254976
author Luo, LiuLin
Liang, Li
Zhang, RanRan
Chen, WeiWei
Yu, FangYou
Zhao, Yanlin
Yue, Jun
author_facet Luo, LiuLin
Liang, Li
Zhang, RanRan
Chen, WeiWei
Yu, FangYou
Zhao, Yanlin
Yue, Jun
author_sort Luo, LiuLin
collection PubMed
description Recently, the incidence of diseases caused by nontuberculous mycobacteria (NTM) has been increasing worldwide, especially in immunocompromised patients and those with potential chronic lung disease. Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and reliable method for identifying mycobacteria in clinical laboratories. This study aimed to evaluate the performance of Vitek MS v3.0 by isolating NTM directly from automated liquid medium systems using patient samples. A total of 855 Mycobacterium growth indicator tube (MGIT)-positive liquid cultures were investigated. Among them, 658 (77.0%) liquid cultures were correctly identified to the species, group, or complex level, 192 (23.0%) resulted in no identification, and 5 (0.6%) were misidentified at the species level. DNA sequencing identified 855 NTM isolates from liquid cultures, comprising 316 isolates of rapidly growing mycobacteria (RGM) and 539 isolates of slow-growing mycobacteria (SGM). Using the Vitek MS system, the RGM integral identification rate (276/316 [87.34%]) was higher than the SGM rate (381/539 [70.69%]) (P < 0.01). It was also higher than the SGM rate for all MGIT report-positive periods. These results indicate that the Vitek MS v3.0 system can rapidly identify NTM species from liquid cultures. Further validation using molecular techniques is required. IMPORTANCE Rapid and accurate identification of nontuberculous mycobacteria (NTM) is essential for diagnosis, appropriate therapy, and infection control. Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and reliable method for identifying mycobacteria in clinical laboratories. This study reported a clinical validation of the Vitek MS V3.0 system for identification of NTM isolates from 855 MGIT-positive liquid cultures which contained relatively large NTM types. Vitek MS v3.0 showed a promising rate for identification NTM isolates in positive liquid cultures. Vitek MS v3.0 had a better performance with RGM than with SGM. Vitek MS v3.0 results included “unidentified” or “misidentified” NTM isolates, which would also serve as an important reference for future optimization of this system. Vitek MS v3.0 represented a valuable technique for NTM identification from positive liquid cultures.
format Online
Article
Text
id pubmed-9769768
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-97697682022-12-22 Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory Luo, LiuLin Liang, Li Zhang, RanRan Chen, WeiWei Yu, FangYou Zhao, Yanlin Yue, Jun Microbiol Spectr Research Article Recently, the incidence of diseases caused by nontuberculous mycobacteria (NTM) has been increasing worldwide, especially in immunocompromised patients and those with potential chronic lung disease. Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and reliable method for identifying mycobacteria in clinical laboratories. This study aimed to evaluate the performance of Vitek MS v3.0 by isolating NTM directly from automated liquid medium systems using patient samples. A total of 855 Mycobacterium growth indicator tube (MGIT)-positive liquid cultures were investigated. Among them, 658 (77.0%) liquid cultures were correctly identified to the species, group, or complex level, 192 (23.0%) resulted in no identification, and 5 (0.6%) were misidentified at the species level. DNA sequencing identified 855 NTM isolates from liquid cultures, comprising 316 isolates of rapidly growing mycobacteria (RGM) and 539 isolates of slow-growing mycobacteria (SGM). Using the Vitek MS system, the RGM integral identification rate (276/316 [87.34%]) was higher than the SGM rate (381/539 [70.69%]) (P < 0.01). It was also higher than the SGM rate for all MGIT report-positive periods. These results indicate that the Vitek MS v3.0 system can rapidly identify NTM species from liquid cultures. Further validation using molecular techniques is required. IMPORTANCE Rapid and accurate identification of nontuberculous mycobacteria (NTM) is essential for diagnosis, appropriate therapy, and infection control. Vitek MS v3.0 matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and reliable method for identifying mycobacteria in clinical laboratories. This study reported a clinical validation of the Vitek MS V3.0 system for identification of NTM isolates from 855 MGIT-positive liquid cultures which contained relatively large NTM types. Vitek MS v3.0 showed a promising rate for identification NTM isolates in positive liquid cultures. Vitek MS v3.0 had a better performance with RGM than with SGM. Vitek MS v3.0 results included “unidentified” or “misidentified” NTM isolates, which would also serve as an important reference for future optimization of this system. Vitek MS v3.0 represented a valuable technique for NTM identification from positive liquid cultures. American Society for Microbiology 2022-10-26 /pmc/articles/PMC9769768/ /pubmed/36287015 http://dx.doi.org/10.1128/spectrum.02018-22 Text en Copyright © 2022 Luo et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Luo, LiuLin
Liang, Li
Zhang, RanRan
Chen, WeiWei
Yu, FangYou
Zhao, Yanlin
Yue, Jun
Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title_full Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title_fullStr Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title_full_unstemmed Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title_short Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory
title_sort using vitek ms v3.0 to identify nontuberculous mycobacteria in liquid media in a clinical microbiology laboratory
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769768/
https://www.ncbi.nlm.nih.gov/pubmed/36287015
http://dx.doi.org/10.1128/spectrum.02018-22
work_keys_str_mv AT luoliulin usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT liangli usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT zhangranran usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT chenweiwei usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT yufangyou usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT zhaoyanlin usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory
AT yuejun usingvitekmsv30toidentifynontuberculousmycobacteriainliquidmediainaclinicalmicrobiologylaboratory